Quick answer
Becton, Dickinson And Company (BDX) reported revenue of $21.84B and net income of $1.68B for the fiscal year ended 2025-09-30, up 8.2% from $20.18B the year before, per its 10-K filed with the SEC on 2025-11-25. Long-term debt stood at $17.62B.
Data as of 2025-09-30. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-09-30) | $21.84B | $1.68B | $17.62B |
| 2024 (FY ending 2024-09-30) | $20.18B | $1.71B | $17.94B |
| 2023 (FY ending 2023-09-30) | $19.37B | $1.48B | $14.74B |
| 2022 (FY ending 2022-09-30) | $18.87B | $1.78B | $13.89B |
| 2021 (FY ending 2021-09-30) | $19.13B | $2.09B | $17.11B |
| 2020 (FY ending 2020-09-30) | $16.07B | $874.0M | $17.22B |
| 2019 (FY ending 2019-09-30) | $17.29B | $1.23B | $18.08B |
| 2018 (FY ending 2018-09-30) | $15.98B | $311.0M | $18.89B |
| 2017 (FY ending 2017-09-30) | $12.09B | $1.10B | $18.67B |
| 2016 (FY ending 2016-09-30) | $12.48B | $976.0M | $10.55B |
Related
- BAM revenue, net income and debt history (Brookfield Asset Management Ltd.)
- BAX revenue, net income and debt history (Baxter International Inc.)
- BBY revenue, net income and debt history (Best Buy Co., Inc.)
- BEN revenue, net income and debt history (Franklin Resources Inc)
- BF-B revenue, net income and debt history (Brown Forman Corp)
- BG revenue, net income and debt history (Bunge Global Sa)
- BIIB revenue, net income and debt history (Biogen Inc.)
- BIO revenue, net income and debt history (Bio-Rad Laboratories, Inc.)
Last updated 2026-10-16. Data only, not financial or tax advice.